ArticleClinical pharmacology and therapeutics2026

Denosumab Offers Relatively Lower Initial Protection Against Osteoporotic Vertebral Fractures in Treatment-Naive Patients Compared With Zoledronate.

Ko-Hsiu Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.